Help us understand the experience of alloimmunization during pregnancy and feasibility of fetal blood type genotyping in Canada

The Alloimmunization During Pregnancy Study aims to better understand the experiences and the financial, social, and economic challenges associated with having testing positive for antibodies (alloimmunization) during pregnancy that needed extra monitoring and care. 

We are also interested in hearing perspectives on fetal blood group genotyping, a maternal blood test that can determine the fetus's blood type and guide alloimmunized care. 

How to participate?
  • We are looking for individuals to participate in two 45-minute interviews or one 90-minute virtual interview (participants choice for two shorter or one longer virtual interview) with a member of the research team to share their experience and perspective.   
  • Participants who complete the interview will receive a $40 gift card. 

Next Steps


A member of the study team will contact only those individuals who are eligible to participate. After completing the screening survey, the research team will review responses to determine eligibility. Eligible participants will be contacted using the email address or telephone number they provided to arrange a brief call, during which the study will be explained in more detail and any questions can be answered.

Prior to the interview, eligible participants will receive an electronic consent form to review and sign, as well as a short questionnaire (approximately 10 minutes) to gather background information and learn more about their experiences with testing positive for antibodies during pregnancy.

Back to News Search

Contact Us

Prenatal Screening Ontario 
CHEO Research Institute 
Centre for Practice-Changing Research Building 
401 Smyth Road 
Ottawa, ON K1H 8L1

pso@bornontario.ca

Information line
Phone: 613-737-2281
Toll-Free: 1-833-351-6490

Monday to Friday, 9:00 AM to 3:00 PM EST

Subscribe to PSO Updates

Subscribe to stay informed about the latest PSO news and prenatal screening updates in Ontario.
Virtual educational sessions on prenatal screening and nuchal translucency quality assurance are available upon request for health‑care providers.